ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Adverse effects"

  • 2020 American Transplant Congress

    Evaluation of Leukopenia and Neutropenia Incidence, Treatment, and Clinical Response in Kidney and Liver Transplant Recipients

    H. Kutzler, T. Webb, R. Cecere, D. O'Sullivan, P. Sheiner

    Hartford Hospital, Hartford, CT

    *Purpose: The purpose is to evaluate incidence, recurrence, therapy modifications, and complications of leukopenia and neutropenia (LN) in kidney (KTR) and liver transplant (LTR) recipients.*Methods:…
  • 2020 American Transplant Congress

    Social Support in the Peri-Liver Transplant Period Affects Post-Transplant Survival, Rejection Rate and Length of Stay

    T. Ashraf1, V. Mendiratta2, S. Gill1, A. Abdelwahab3, D. Moonka2, S. Jafri2

    1Internal Medicine, Henry Ford Hospital, Detroit, MI, 2Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, MI, 3Wayne State University, Detroit, MI

    *Purpose: Although social support is a key component of the pre-transplant evaluation, it’s effect on post-transplant outcomes remains understudied. The purpose of this study was…
  • 2020 American Transplant Congress

    Safety and Effectiveness of Early Initiation of SGLT2 Inhibitors in Diabetic Kidney Transplant Recipients

    C. Song1, R. Winstead1, A. Brown1, M. Demehin1, I. Yakubu1, I. Moinuddin2, G. Gupta2

    1Pharmacy, Virginia Commonwealth University Health, Richmond, VA, 2Virginia Commonwealth University Health, Richmond, VA

    *Purpose: Metabolic complications such as post-transplant diabetes (PTDM) are quickly becoming the leading causes of death in kidney transplant (KT) recipients. The use of Sodium…
  • 2020 American Transplant Congress

    Treatment of Hepatic Encephalopathy in Cirrhotic Patients: Does Rifaximin Prevent Clostridioides Difficile Infection? A Retrospective Analysis

    J. D. Goldman, V. Aleksenko, J. L. Davila, N. A. Muhktar, K. Kowdley

    Swedish Medical Center, Seattle, WA

    *Purpose: Clostridioides difficile infection (CDI) is a major cause of morbidity and mortality and new prevention strategies in high-risk patients are needed. Rifaximin has been…
  • 2020 American Transplant Congress

    Safety and Efficacy of Valganciclovir for Cytomegalovirus Prophylaxis in Solid Organ Transplant Patients on Hemodialysis

    D. E. Ecabert, C. Pham, B. J. Pierce, W. L. Musick

    Houston Methodist Hospital, Houston, TX

    *Purpose: Cytomegalovirus (CMV) is the most common viral infection after solid organ transplant (SOT) and is associated with significant morbidity and mortality. Valganciclovir (VGCV) is…
  • 2020 American Transplant Congress

    A Prospective Randomized Multicenter Trial (BEST Trial) of Belatacept-Based CNI- and Corticosteroid-Free Immunosuppression: Infectious Complications

    P. West-Thielke1, A. Shields2, D. Kaufman3, J. Leone4, A. Wiseman5, A. Matas6, T. Sa7, E. King7, R. Alloway2, S. Woodle2

    1University of Illinois, Chicago, IL, 2University of Cincinnati, Cincinnati, OH, 3University of Wisconsin, Madison, IL, 4Tampa General Hospital, Tampa, FL, 5University of Colorado, Aurora, CO, 6University of Minnesota, Minneapolis, MN, 7Cincinnati Children's Hospital Medical Center, Cincinnati, OH

    *Purpose: The BEST Trial (Belatacept-based Early Steroid Withdrawal Trial) is a prospective, randomized, multi-center trial designed to compare two belatacept (BELA)-based calcineurin inhibitor-free (CNI), early…
  • 2020 American Transplant Congress

    Contrary to Expectation, the Use of Immune Checkpoint Inhibitors is Not Consistently Associated with Early Onset Allograft Rejection in Solid Organ Transplant Recipients

    I. Owoyemi1, C. M. Costello2, C. Thongprayoon1, S. Markovic3, H. Joerg4, C. C. Otley5, T. Taner6, A. R. Mangold2, N. Leung1, S. Herrmann1, A. Kukla1

    1Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, 2Department of Dermatology, Mayo Clinic, Scottsdale, AZ, 3Division of Medical Oncology, Mayo Clinic, Rochester, MN, 4Department of Cardiology, Mayo Clinic, Rochester, MN, 5Department of Dermatology, Mayo Clinic, Rochester, MN, 6Departments of Surgery & Immunology, Mayo Clinic, Rochester, MN

    *Purpose: Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy but are generally avoided in solid organ transplant recipients (SOTRs) due to concern for allograft rejection…
  • 2020 American Transplant Congress

    Successful Use of Tedizolid for the Treatment of Nocardiosis in Transplant Recipients

    R. Odrobina1, B. Tritle2, C. A.Gomez1

    1Division of Infectious Diseases, University of Utah, Salt Lake City, UT, 2Department of Pharmacy, University of Utah, Salt Lake City, UT

    *Purpose: Nocardiosis is an opportunistic infection occasionally seen after solid organ (SOT) and hematopoietic stem-cell transplantation. Treatment is challenging due to the limited number of…
  • 2020 American Transplant Congress

    Patient Reported Medication Nonadherence and Tolerability: Results of a Prospective Observational Study

    D. Taber, N. Patel, K. Foster, F. Bartlett, C. Perez, H. Meadows, N. Pilch, A. Posadas, K. Soliman, V. Rao, M. Casey, V. Rohan, J. McGillicuddy, S. Nadig, D. Dubay

    MUSC, Charleston, SC

    *Purpose: Medication nonadherence (MNA) is a major contributor to late allograft loss in transplantation (txp). Immunosuppression therapy is highly effective at preventing rejection yet presents…
  • 2020 American Transplant Congress

    Implementation of a Pharmacist in an Adult Transplant Outpatient Clinic (Kidney, Liver, Pancreas): A Pilot Study – Implant

    P. Leveille-Dugas1, C. Bernard1, L. Loiselle1, Y. Zhang1, C. Coursol1, K. Mousseau1, N. Sheehan1, M. Cantarovich2

    1Pharmacy, McGill University Health Centre, Montréal, QC, Canada, 2Division of Nephrology, Department of Medicine, McGill University Health Centre, Montréal, QC, Canada

    *Purpose: Solid organ transplant (SOT) patients require a complex medication regimen which increases the risk of many drug-related problems. The purpose of this study was…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 18
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences